Algorithm to Adoption
Pathology AI Consulting
Artificial intelligence holds immense promise for diagnostic pathology, but the path from algorithm to clinical adoption is complex. We help organizations navigate validation, workflow integration, and the commercial realities of AI in healthcare.
Who this service helps
- AI developers entering the digital pathology market
- Pathology practices evaluating clinical AI tools
- Investors conducting due diligence on pathology AI companies
- Regulatory and quality teams planning algorithm validation
What the work can accomplish
- Clear frameworks for clinical validation and performance monitoring
- Strategies for integrating AI outputs into the primary diagnostic workflow
- Commercial positioning that moves beyond hype to operational ROI
- Assessment of technical readiness and data infrastructure requirements
How we approach it
- We evaluate AI tools based on clinical utility: do they improve accuracy, speed, or standardization?
- We design integration strategies that place AI insights directly in the pathologist's line of sight without disrupting their rhythm.
- We help laboratories build the IT and data governance necessary to deploy and monitor algorithms safely.
- We advise vendors on how to structure pricing models that align with laboratory economics.
Experienced pathology leadership
David “DJ” Dalton, PhD, MBA brings more than 20 years of pathology industry experience spanning Labcorp, Paige AI, Lumea/Modella AI, digital pathology, laboratory operations, product strategy, commercialization, and executive leadership.
Last reviewed September 2026. About David Dalton
Frequently asked questions
Will AI replace pathologists?
No. AI will augment pathologists by automating tedious tasks (like counting mitoses or finding rare micro-metastases) and providing quality assurance. The immediate future is augmented intelligence, not autonomous diagnosis.
How do laboratories pay for pathology AI?
Funding often comes from operational budgets justified by measurable efficiency or quality improvements. In some use cases, reimbursement may contribute, but coverage varies and continues to evolve. Vendors should build an evidence-based value case for each customer.
What is required to validate an AI algorithm for clinical use?
Validation generally includes testing the algorithm against the laboratory's stains, scanners, tissue types, case mix, intended use, and local workflow. The exact plan should reflect applicable regulatory requirements, accreditation guidance, and the laboratory's own quality system.